The Cohort Study of Uveitis Patients Based on Real-world Data
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
研究概览
简要总结
This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The diagnosis is uveitis; The agreement of enrolling this study;
排除标准
- •Uveitis during the first month after any intraocular surgery; <18 years; pregnant and lactating women; other conditions are unsuitable for participation in this study by the investigator such as mental abnormalities.
结局指标
主要结局
The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
时间窗: 12 months post-treatment
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions
时间窗: 12 months post-treatment
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
次要结局
- The number of intraocular pressure(6 months post-treatment)
- The number of Intraocular pressure(36 months post-treatment)
- Central retinal thickness(36 months post-treatment)
- The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions(36 months post-treatment)
- Best corrected visual acuity(36 months post-treatment)
- The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system(36 months post-treatment)